Research emanating from this long-established group has had a considerable impact. Within an academic context, group members disseminate their research results in peer-reviewed journal publications and at major international conferences, and the group collaborate with many leading academic research groups around the world. Outside of academia, many well-known companies have benefited from the group’s expertise through consultancy and/or collaborative research projects, e.g., AstraZeneca, Johnson Matthey, P&G and Pfizer. Furthermore, the group have a strong track record of research commercialisation. Two software companies, DEM Solutions and Particle Analytics, have been formed as spin-out companies from this group, and in 2016 Freeman Technology launched the Uniaxial Powder Tester based on IP licensed from Edinburgh.
In recent years, the group have been highly successful in winning research funding from EPSRC, the European Union, the Royal Society and IFPRI, in addition to industrial funding. The group at Edinburgh currently coordinate the EU FP7 Marie Curie Initial Training Network T-MAPPP (2014–2018), which follows on from a previous highly successful FP7 project PARDEM (2009–2013).